Very Few Patients With HIV Report Using Long-Acting Injectable ART

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, April 29, 2026 -- Despite patients reporting preference for long-acting injectable antiretroviral therapy (LAI-ART), few patients with HIV (PWH) report using LAI-ART, according to a study published recently in the Journal of Acquired Immune Deficiency Syndromes.

Noting that LAI-ART has potential to contribute to improving HIV outcomes and quality of life in PWH, Deanna Kerrigan, Ph.D., from the George Washington University Milken Institute School of Public Health in Washington, D.C., and colleagues examined factors associated with LAI-ART versus daily oral ART preferences among 801 PWH who completed a survey that included 54 items.

Overall, 2.8 percent of participants were using LAI-ART. The researchers found that 56.9 percent preferred LAI-ART administered monthly compared with daily oral ART, and 68.0 percent preferred LAI-ART administered once every two months. Medication/contraception injection experience, pill burden, no medication other than ART, four or more clinic visits per year, detectable viral load, reporting a higher number of HIV treatment considerations, and identifying as Black were factors associated with greater odds of LAI-ART preference. Older age, identifying as neither gay nor straight, living more than one hour from the clinic, and considerable/extreme needle fear were factors associated with reduced odds of LAI-ART preference.

"There's clearly something that is limiting the ability of patients to translate their preferences into actually being on the medicine," Kerrigan said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-30 09:35

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords